Endo Pharmaceuticals to Develop and Commercialize Alexza's AZ-003 Staccato(R) Inhaled Fentanyl Product (Marketwire via Yahoo! Finance)
Endo Pharmaceuticals Holdings Inc., a market leader in pain management, today announced that it has entered into a license and development agreement with Alexza Pharmaceuticals, Inc. for the exclusive clinical development and commercialization rights in North America for Alexza's AZ-003 (Staccato fentanyl).

Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules (wallstreet:online AG)
Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that the U.S. Food and Drug Administration